Amulet Capital Partners LP has formed CC Amulet Management LLC, a specialty dental platform that will provide business and practice management services to Children’s Choice Pediatric Dental Care, a California-based dental services provider focused on children, infants, adolescents and those with special needs. No financial terms were disclosed. McDermott Will & Emery advised Amulet on the transaction.
SACRAMENTO, Calif. & GREENWICH, Conn.–(BUSINESS WIRE)–Amulet Capital Partners, LP (“Amulet”), a healthcare private equity investment firm based in Greenwich, Connecticut, today announced that it has formed CC Amulet Management, LLC (the “Company”), to provide business and practice management services to Children’s Choice Pediatric Dental Care (“Children’s Choice”), a California-based dental services provider focused on delivering care to children, infants, adolescents and those with special needs.
Terms of the transaction were not disclosed.
The Company will be headquartered in Sacramento, California, and offer business and practice management services to dental practices that serve pediatric patients through both commercial and state/federal-assisted programs across 16 practice locations throughout California. The CEO and Founder of Children’s Choice, Dr. Jeffrey Saladin, will continue to own and run the day-to-day operations of Children’s Choice and will be a significant shareholder in the Company.
Dr. Saladin commented, “Children’s Choice was founded with the mission to provide pediatric patients with access to the highest quality dental care. I am excited to be partnering with Amulet and the Company as we embark upon our next phase of growth.”
Jay Rose, Partner and Co-Founder of Amulet said, “Access to oral health care continues to be a significant issue not only within California but across the country. We believe that Children’s Choice’s preventative care focus is particularly well suited for the pediatric and traditionally underserved patient populations to whom it currently provides care. As a value-added partner, we believe our history in this segment, along with a favorable macro regulatory and reimbursement environment, makes this an attractive investment for our fund. We are proud to partner with Dr. Saladin and his team and believe there is a significant opportunity for continued and accelerated growth – both organically and through strategic acquisitions.”
Amulet Capital Partners was advised by McDermott Will & Emery in the transaction.
About Amulet Capital Partners, LP
Amulet Capital Partners, LP is a healthcare private equity investment firm based in Greenwich, CT. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million. Amulet Capital Partners’ investment team has approximately 50 years of private equity experience. For additional information, please visit www.amuletcapital.com.